Prognostic and therapeutic role of a novel genomic subtyping of target gene sequencing on gastroenteropancreatic neuroendocrine carcinoma

#3657

Introduction: Despite of emerging genomic discoveries, no optimal management for gastroenteropancreatic neuroendocrine carcinoma (GEPNEC) were found.

Aim(s): We sought to investigate genomic subtyping using tumor DNA in GEPNEC to reveal its potential prognostic and predictive value.

Materials and methods: Driver genes were identified using target-sequencing sequencing to classify patients by primary sites and genomic features.

Conference:

Presenting Author:

Authors: Zhang J, Li J, Lu M, Sun Y, Shen L,

Keywords: Gastroenteropancreatic Neuroendocrine carcinoma, Target gene sequencing, Genomic subtyping, Efficacy, Prognosis, Second-line treatment,